Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa.

Caruso MP, Falivene J, Holgado MP, Zurita DH, Laufer N, Castro C, Nico Á, Maeto C, Salido J, Pérez H, Salomón H, Cahn P, Sued O, Fink V, Turk G, Gherardi MM.

Sci Rep. 2019 Feb 13;9(1):1978. doi: 10.1038/s41598-019-38547-1.

2.

Phenotype, Polyfunctionality, and Antiviral Activity of in vitro Stimulated CD8+ T-Cells From HIV+ Subjects Who Initiated cART at Different Time-Points After Acute Infection.

Salido J, Ruiz MJ, Trifone C, Figueroa MI, Caruso MP, Gherardi MM, Sued O, Salomón H, Laufer N, Ghiglione Y, Turk G.

Front Immunol. 2018 Oct 23;9:2443. doi: 10.3389/fimmu.2018.02443. eCollection 2018.

3.

PD-1 Expression in HIV-Specific CD8+ T cells Before Antiretroviral Therapy Is Associated With HIV Persistence.

Ghiglione Y, Trifone C, Salido J, Rhodes A, Ruiz MJ, Polo ML, Salomón H, Laufer N, Sued O, Lewin SR, Turk G.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):1-6. doi: 10.1097/QAI.0000000000001887.

PMID:
30399040
4.
5.

Computational comparison of availability in CTL/gag epitopes among patients with acute and chronic HIV-1 infection.

Damilano GD, Sued O, Ruiz MJ, Ghiglione Y, Canitano F, Pando M, Turk G, Cahn P, Salomón H, Dilernia D.

Vaccine. 2018 Jun 27;36(28):4142-4151. doi: 10.1016/j.vaccine.2018.04.086. Epub 2018 May 22.

PMID:
29802001
6.

Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?

Turk G, Ghiglione Y, Hormanstorfer M, Laufer N, Coloccini R, Salido J, Trifone C, Ruiz MJ, Falivene J, Holgado MP, Caruso MP, Figueroa MI, Salomón H, Giavedoni LD, Pando MLÁ, Gherardi MM, Rabinovich RD, Pury PA, Sued O.

Viruses. 2018 Jan 13;10(1). pii: E34. doi: 10.3390/v10010034.

7.

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors.

Salazar R, Garcia-Carbonero R, Libutti SK, Hendifar AE, Custodio A, Guimbaud R, Lombard-Bohas C, Ricci S, Klümpen HJ, Capdevila J, Reed N, Walenkamp A, Grande E, Safina S, Meyer T, Kong O, Salomon H, Tavorath R, Yao JC.

Oncologist. 2018 Jul;23(7):766-e90. doi: 10.1634/theoncologist.2017-0144. Epub 2017 Dec 14.

8.

Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates.

Ruiz MJ, Salido J, Abusamra L, Ghiglione Y, Cevallos C, Damilano G, Rodriguez AM, Trifone C, Laufer N, Giavedoni LD, Sued O, Salomón H, Gherardi MM, Turk G.

EBioMedicine. 2017 Dec;26:25-37. doi: 10.1016/j.ebiom.2017.11.001. Epub 2017 Nov 3.

9.

Expansion of CD25-Negative Forkhead Box P3-Positive T Cells during HIV and Mycobacterium tuberculosis Infection.

Angerami MT, Suarez GV, Vecchione MB, Laufer N, Ameri D, Ben G, Perez H, Sued O, Salomón H, Quiroga MF.

Front Immunol. 2017 May 9;8:528. doi: 10.3389/fimmu.2017.00528. eCollection 2017.

10.

Prevalence of rilpivirine resistance in people starting antiretroviral treatment in Argentina.

Bissio E, Barbás MG, Kademián S, Bouzas MB, Salomón H, Cudolá A, Giuliano SF, Falistocco C.

Antivir Ther. 2017;22(7):625-629. doi: 10.3851/IMP3147. Epub 2017 Feb 24.

PMID:
28234630
11.

Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.

Smith I, Yardley D, Burris H, De Boer R, Amadori D, McIntyre K, Ejlertsen B, Gnant M, Jonat W, Pritchard KI, Dowsett M, Hart L, Poggio S, Comarella L, Salomon H, Wamil B, O'Shaughnessy J.

J Clin Oncol. 2017 Apr 1;35(10):1041-1048. doi: 10.1200/JCO.2016.69.2871. Epub 2017 Jan 23. Erratum in: J Clin Oncol. 2019 Feb 1;37(4):359.

PMID:
28113032
12.

Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.

Bissio E, Barbás MG, Bouzas MB, Cudolá A, Salomón H, Espínola L, Fernández Giuliano S, Kademián S, Mammana L, Ornani ML, Ravasi G, Vila M, Zapiola I, Falistocco C.

J Antimicrob Chemother. 2017 Feb;72(2):504-510. doi: 10.1093/jac/dkw445. Epub 2016 Oct 26.

PMID:
27789684
13.

Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity.

Ruiz MJ, Ghiglione Y, Falivene J, Laufer N, Holgado MP, Socías ME, Cahn P, Sued O, Giavedoni L, Salomón H, Gherardi MM, Rodríguez AM, Turk G.

J Virol. 2016 Jan 15;90(2):670-81. doi: 10.1128/JVI.02363-15. Print 2016 Jan 15.

14.

Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression.

Falivene J, Ghiglione Y, Laufer N, Socías ME, Holgado MP, Ruiz MJ, Maeto C, Figueroa MI, Giavedoni LD, Cahn P, Salomón H, Sued O, Turk G, Gherardi MM.

Sci Rep. 2015 Jun 23;5:11511. doi: 10.1038/srep11511.

15.

HIV-TB coinfection impairs CD8(+) T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses.

Suarez GV, Angerami MT, Vecchione MB, Laufer N, Turk G, Ruiz MJ, Mesch V, Fabre B, Maidana P, Ameri D, Cahn P, Sued O, Salomón H, Bottasso OA, Quiroga MF.

Eur J Immunol. 2015 Sep;45(9):2529-41. doi: 10.1002/eji.201545545. Epub 2015 Jun 22.

16.

Host genetic factors associated with symptomatic primary HIV infection and disease progression among Argentinean seroconverters.

Coloccini RS, Dilernia D, Ghiglione Y, Turk G, Laufer N, Rubio A, Socías ME, Figueroa MI, Sued O, Cahn P, Salomón H, Mangano A, Pando MÁ.

PLoS One. 2014 Nov 18;9(11):e113146. doi: 10.1371/journal.pone.0113146. eCollection 2014.

17.

Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression.

Ghiglione Y, Falivene J, Ruiz MJ, Laufer N, Socías ME, Cahn P, Giavedoni L, Sued O, Gherardi MM, Salomón H, Turk G.

PLoS One. 2014 Aug 5;9(8):e104235. doi: 10.1371/journal.pone.0104235. eCollection 2014.

18.

Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina.

Rubio AE, Abraha A, Carpenter CA, Troyer RM, Reyes-Rodríguez ÁL, Salomon H, Arts EJ, Tebit DM.

PLoS One. 2014 Apr 11;9(4):e92084. doi: 10.1371/journal.pone.0092084. eCollection 2014.

19.

Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina.

Rodriguez-Rodrigues N, Duran A, Bouzas MB, Zapiola I, Vila M, Indyk D, Bissio E, Salomon H, Dilernia DA.

J Int AIDS Soc. 2013 Oct 3;16:18519. doi: 10.7448/IAS.16.1.18519.

20.

Mother-to-Child Transmission of Hepatitis C Virus (HCV) Among HIV/HCV-Coinfected Women.

Checa Cabot CA, Stoszek SK, Quarleri J, Losso MH, Ivalo S, Peixoto MF, Pilotto JH, Salomon H, Sidi LC, Read JS; NICHD International Site Development Initiative Perinatal/Longitudinal Study in Latin American Countries Study Group.

J Pediatric Infect Dis Soc. 2013 Jun;2(2):126-35. doi: 10.1093/jpids/pis091. Epub 2012 Oct 11.

21.

Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.

Turk G, Ghiglione Y, Falivene J, Socias ME, Laufer N, Coloccini RS, Rodriguez AM, Ruiz MJ, Pando MÁ, Giavedoni LD, Cahn P, Sued O, Salomon H, Gherardi MM.

J Virol. 2013 Jul;87(13):7445-62. doi: 10.1128/JVI.00865-13. Epub 2013 Apr 24.

22.

Modulation of the phenotype and function of Mycobacterium tuberculosis-stimulated dendritic cells by adrenal steroids.

Angerami M, Suarez G, Pascutti MF, Salomon H, Bottasso O, Quiroga MF.

Int Immunol. 2013 Jul;25(7):405-11. doi: 10.1093/intimm/dxt004. Epub 2013 Feb 26.

PMID:
23446847
23.

Estimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population level.

Dilernia DA, Monaco DC, Cesar C, Krolewiecki AJ, Friedman SR, Cahn P, Salomon H.

PLoS One. 2013;8(1):e53193. doi: 10.1371/journal.pone.0053193. Epub 2013 Jan 7.

24.

Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients.

Arruvito L, Sabatté J, Pandolfi J, Baz P, Billordo LA, Lasala MB, Salomón H, Geffner J, Fainboim L.

PLoS One. 2012;7(12):e52580. doi: 10.1371/journal.pone.0052580. Epub 2012 Dec 20.

25.

Human immunodeficiency virus-1 BF intersubtype recombinant viral protein U second α helix plays an important role in viral release and BST-2 degradation.

De Candia C, Espada C, Duette G, Salomón H, Carobene M.

J Gen Virol. 2013 Apr;94(Pt 4):758-66. doi: 10.1099/vir.0.047746-0. Epub 2012 Dec 5.

PMID:
23223624
26.

ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosis.

Jurado JO, Pasquinelli V, Alvarez IB, Martínez GJ, Laufer N, Sued O, Cahn P, Musella RM, Abbate E, Salomón H, Quiroga MF.

J Int AIDS Soc. 2012 Jun 14;15(2):17428. doi: 10.7448/IAS.15.2.17428.

27.

Improved strategies for HIV diagnosis among men who have sex with men (MSM) in Buenos Aires, Argentina, a population with a high prevalence and incidence of HIV infection.

Pando MA, Coloccini RS, Schvachsa N, Pippo M, Alfie LG, Marone R, Gomez-Carrillo M, Avila MM, Salomón H.

HIV Med. 2012 Oct;13(9):564-7. doi: 10.1111/j.1468-1293.2012.01011.x. Epub 2012 Mar 21.

28.

Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive persons.

Quiroga MF, Angerami MT, Santucci N, Ameri D, Francos JL, Wallach J, Sued O, Cahn P, Salomón H, Bottasso O.

PLoS One. 2012;7(3):e33061. doi: 10.1371/journal.pone.0033061. Epub 2012 Mar 14.

29.

No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy.

Laufer N, Abusamra L, Bolcic F, Gun A, Rolón MJ, Pérez H, Krolewiecki A, Salomón H, Quarleri J, Cahn P.

Antiviral Res. 2011 Dec;92(3):497-9. doi: 10.1016/j.antiviral.2011.10.006. Epub 2011 Oct 13.

PMID:
22020160
30.

HIV-mediated up-regulation of invariant chain (CD74) correlates with generalized immune activation in HIV+ subjects.

Ghiglione Y, Rodríguez AM, De Candia C, Carobene M, Benaroch P, Schindler M, Salomón H, Turk G.

Virus Res. 2012 Jan;163(1):380-4. doi: 10.1016/j.virusres.2011.09.011. Epub 2011 Sep 16.

PMID:
21945129
31.

Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues.

Jones LR, Moretti F, Calvo AY, Dilernia DA, Manrique JM, Gómez-Carrillo M, Salomón H.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):949-55. doi: 10.1089/AID.2011.0287. Epub 2011 Nov 22.

32.

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.

Socías ME, Sued O, Laufer N, Lázaro ME, Mingrone H, Pryluka D, Remondegui C, Figueroa MI, Cesar C, Gun A, Turk G, Bouzas MB, Kavasery R, Krolewiecki A, Pérez H, Salomón H, Cahn P; Grupo Argentino de Seroconversión Study Group.

J Int AIDS Soc. 2011 Aug 10;14:40. doi: 10.1186/1758-2652-14-40.

33.

Acute HIV seroconversion presenting with active tuberculosis and associated with high levels of T-regulatory cells.

Sued O, Quiroga MF, Socías ME, Turk G, Salomón H, Cahn P.

Viral Immunol. 2011 Aug;24(4):347-9. doi: 10.1089/vim.2010.0101. Epub 2011 Jul 20.

34.

HCV RNA decline in the first 24 h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin.

Laufer N, Bolcic F, Rolón MJ, Martinez A, Reynoso R, Pérez H, Salomón H, Cahn P, Quarleri J.

Antiviral Res. 2011 Apr;90(1):92-7. doi: 10.1016/j.antiviral.2011.02.013. Epub 2011 Mar 2.

35.

[The importance of early diagnosis for the survival of HIV positive patients].

Dilernia DA, Mónaco DC, Krolewiecki A, César C, Cahn P, Salomón H.

Medicina (B Aires). 2010;70(5):453-6. Spanish.

PMID:
20920966
36.

Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein.

De Candia C, Espada C, Duette G, Ghiglione Y, Turk G, Salomón H, Carobene M.

Virol J. 2010 Oct 4;7:259. doi: 10.1186/1743-422X-7-259.

37.

Analysis of HIV type 1 BF recombinant sequences from South America dates the origin of CRF12_BF to a recombination event in the 1970s.

Dilernia DA, Jones LR, Pando MA, Rabinovich RD, Damilano GD, Turk G, Rubio AE, Pampuro S, Gomez-Carrillo M, Salomón H.

AIDS Res Hum Retroviruses. 2011 May;27(5):569-78. doi: 10.1089/aid.2010.0118. Epub 2010 Dec 3.

38.

Incidence of HIV type 1 infection, antiretroviral drug resistance, and molecular characterization in newly diagnosed individuals in Argentina: A Global Fund Project.

Pando MA, Gómez-Carrillo M, Vignoles M, Rubio AE, dos Ramos Farias MS, Vila M, Rossi D, Ralón G, Marone R, Reynaga E, Sosa J, Torres O, Maestri M, Avila MM, Salomón H.

AIDS Res Hum Retroviruses. 2011 Jan;27(1):17-23. doi: 10.1089/aid.2010.0013. Epub 2010 Sep 23.

39.

Hepatitis B virus, hepatitis C virus and HIV coinfection among people living with HIV/AIDS in Buenos Aires, Argentina.

Laufer N, Quarleri J, Bouzas MB, Juncos G, Cabrini M, Moretti F, Bolcic F, Fernández-Giuliano S, Mammana L, Salomón H, Cahn P.

Sex Transm Dis. 2010 May;37(5):342-3. doi: 10.1097/OLQ.0b013e3181d73c0d. No abstract available.

40.

Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.

Vignoles M, Barboni G, Agosti MR, Quarleri J, García MK, Ayala SG, Salomón H.

Antivir Ther. 2009;14(8):1175-81. doi: 10.3851/IMP1461.

PMID:
20032547
41.

In-depth analysis of the origins of HIV type 1 subtype C in South America.

Jones LR, Dilernia DA, Manrique JM, Moretti F, Salomón H, Gomez-Carrillo M.

AIDS Res Hum Retroviruses. 2009 Oct;25(10):951-9. doi: 10.1089/aid.2008.0293.

PMID:
19842791
42.

Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: a 3-yr prospective study.

Cassino L, Laufer N, Salomon H, Campos R, Quarleri J.

J Clin Virol. 2009 Dec;46(4):354-9. doi: 10.1016/j.jcv.2009.09.015. Epub 2009 Oct 2.

PMID:
19800842
43.

Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12_BF revealed high immune specificity with low cross-reactivity against subtype B.

Rodríguez AM, Turk G, Pascutti MF, Ferrer F, Nájera JL, Mónaco D, Esteban M, Salomón H, Calamante G, Gherardi MM.

Virus Res. 2009 Dec;146(1-2):1-12. doi: 10.1016/j.virusres.2009.08.004. Epub 2009 Aug 26.

PMID:
19715734
44.

Single and multiple mutations in the human cytomegalovirus UL97 gene and their relationship to the enzymatic activity of UL97 kinase for ganciclovir phosphorylation.

Sanchez Puch SI, Mathet VL, Porta M, Cuestas ML, Oubiña JR, Videla CM, Salomón HE.

Antiviral Res. 2009 Nov;84(2):194-8. doi: 10.1016/j.antiviral.2009.08.005. Epub 2009 Aug 25.

PMID:
19712701
45.

In vitro dynamics of HIV-1 BF intersubtype recombinants genomic regions involved in the regulation of gene expression.

Carobene MG, Rodríguez Rodrígues C, De Candia CA, Turk G, Salomón H.

Virol J. 2009 Jul 16;6:107. doi: 10.1186/1743-422X-6-107.

46.

Single Nef proteins from HIV type 1 subtypes C and F fail to upregulate invariant chain cell surface expression but are active for other functions.

Turk G, Gundlach S, Carobene M, Schindler M, Salomon H, Benaroch P.

AIDS Res Hum Retroviruses. 2009 Mar;25(3):285-96. doi: 10.1089/aid.2008.0132.

PMID:
19327048
47.

Antiretroviral activity of fucoidans extracted from the brown seaweed Adenocystis utricularis.

Trinchero J, Ponce NM, Córdoba OL, Flores ML, Pampuro S, Stortz CA, Salomón H, Turk G.

Phytother Res. 2009 May;23(5):707-12. doi: 10.1002/ptr.2723.

PMID:
19107862
48.

HLA-driven convergence of HIV-1 viral subtypes B and F toward the adaptation to immune responses in human populations.

Dilernia DA, Jones L, Rodriguez S, Turk G, Rubio AE, Pampuro S, Gomez-Carrillo M, Bautista CT, Deluchi G, Benetucci J, Lasala MB, Lourtau L, Losso MH, Perez H, Cahn P, Salomón H.

PLoS One. 2008;3(10):e3429. doi: 10.1371/journal.pone.0003429. Epub 2008 Oct 21. Erratum in: PLoS One. 2008;3(11). doi: 10.1371/annotation/bffe1c6a-4d1e-46bb-a8dc-648a4f566a19. Bautista, Christian [corrected to Bautista, Christian T].

49.

Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.

Bolcic F, Bull L, Martinez L, Reynoso R, Salomon H, Arduino R, Barnett B, Quarleri J.

Intervirology. 2008;51(4):261-4. doi: 10.1159/000158523. Epub 2008 Sep 30. No abstract available.

PMID:
18824873
50.

Uncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme.

Laufer N, Cassino L, Bolcic F, Moretti F, Reynoso R, Bouzas MB, Cahn P, Salomón H, Quarleri J.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):233-4. doi: 10.1097/QAI.0b013e31816de85f. No abstract available.

Supplemental Content

Loading ...
Support Center